Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Insulin

Research Leaders

7 sponsors active, led by Suxia Li

Related Conditions

Often studied with 17 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (4)
Phase 3 (1)

Trial Status

Recruiting4
Not Yet Recruiting2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (7)

Research Network

Common Treatments

  • Insulin1
  • Allogeneic Natural Killer Nkcell Transplantation1
  • Suturefree Ophthalmic Hydrogel For Ocular Surface Surgery1
  • Transscleral Cyclphophotocoagulation Using The Micropulse System Iridex Iq810 Laser Systems Mountain View Ca1
  • Gprobe Transscleral Cyclphophotocoagulation Iris Medical Instruments Montain View Ca1

Active Sponsors

  • Suxia Li3
  • University Clinic for Ophthalmology and Optometry- Salzburg1
  • IRCCS San Raffaele1
  • University of Campinas, Brazil1
  • Fonds de recherche en ophtalmologie de l'Université de Montréal1

Top Investigators

Related Conditions

  • Cornea Inflamed2
  • Eye Diseases2
  • Eye Lesion1
  • Cornea Infection1
  • Cornea Injury Abrasion1

Activity Timeline